COVID emerged suddenly, spread rapidly and killed millions of people around the world. Since then, I think it’s fair to say ...
With COVID in retreat (thanks to highly effective vaccines), the three infectious diseases causing public health officials the greatest concern are malaria (a parasite), HIV (a virus ... receptors on ...
The human immune deficiency virus (HIV) first entered public consciousness in the early 1980s, after cases of unfamiliar and ...
NanoViricides, Inc. (NYSE American:NNVC) (the 'Company'), says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to ...
In a new study, Weizmann Institute of Science researchers reveal a bacterial immune system that thwarts the phages’ plot by attaching a small protein molecule to their tails. The components of this ...
Women remain disproportionately affected by HIV worldwide. According to UNAIDS, in Sub-Saharan Africa, women and girls account for 62 per cent of new HIV infections.
The winter virus season comes with sniffles and coughs accompanying holiday tunes. For anyone who doesn’t want to climb out ...
New research shows that the lockdowns during the COVID-19 pandemic had a significant impact on people's immune response to microorganisms. During the lockdown, inflammation level in the body was low, ...
Over 800 million people have genital herpes — and in many cases the virus can flare up over a person's lifetime, causing ...
Researchers at the University of Hawai'i at Mānoa have discovered that a virus, FloV-SA2, encodes one of the proteins needed ...
Yesterday, 38 leading biologists joined together to issue a warning about the fascinating yet terrifying new technology ...
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.